|本期目录/Table of Contents|

[1]赵昊云,张承,杨林东综述,等.卵巢癌的脑转移诊疗进展[J].医学研究与战创伤救治(原医学研究生学报),2016,18(02):180-181,208.[doi:10.3969/j.issn.1672-271X.2016.02.022]
点击复制

卵巢癌的脑转移诊疗进展()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第18卷
期数:
2016年02期
页码:
180-181,208
栏目:
综述
出版日期:
2016-04-09

文章信息/Info

Title:
-
作者:
赵昊云; 张承; 杨林东综述; 吴元赭审校
210002 江苏南京，南京军区南京总医院妇产科
Author(s):
-
关键词:
卵巢癌; 脑转移; 诊断; 治疗
Keywords:
-
分类号:
R737.31
DOI:
10.3969/j.issn.1672-271X.2016.02.022
文献标志码:
A
摘要:
随着医疗技术的发展，卵巢癌患者的生存期较以前明显延长，因此，晚期卵巢癌转移至脑也较以前明显增多，本文主要综述晚期卵巢癌脑转移的高危因素、临床症状、诊断、治疗及预后情况。
Abstract:
-

参考文献/References:

[1]Rebecca S, Deepa N, Ahmedin J. Cancer statistics 2012[J]. CA Cancer J Clin, 2012, 62(1): 10-29.
[2]Cannistra SA. Cancer of the ovary[J].N Engl J Med, 2004,351(24):2519-2529.
[3]Nasu K, Satoh T, Nishio S, et al. Clinicopathologic features of brain metastases from gynecologic malignancies a retrospective study of 139 cases (KCOG-G1001s trial)[J]. Gynecol Oncol, 2013, 128(2): 198-203.
[4]Sehouli J, Pietzner K, Harter P, et al. Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study [J].Ann Oncol, 2010, 21: 2201-2205.
[5]Cormio G, Loizzi V, Falagario M, et al. Central nervous system metastases from epithelial ovarian cancer (prognostic factors and outcomes)[J]. Int J Gynecol Cancer，2011，21(5): 816-821.
[6]Matsuo K, Eno ML, Ahn EH,et al. Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer[J]. Am J Clin Oncol，2011,34(5):488-493.
[7]Chen YL, Cheng WF, Hsieh CY,et al. Brain metastasis as a late manifestation of ovarian carcinoma[J]. Eur J Cancer Care，2011,20(1):44-49.
[8]Stein M, Steiner M, Ben-Schachar M, et al.Leptomeningeal involvement by epithelial ovarian carcinoma: a case report[J]. Gynecol Oncol，1987，27(2):241-245.
[9]Cormio G, Rossi C, Cazzolla A, et al. Distant metastases in ovarian carcinoma[J]. INT J Gynecol Cancer, 2003, 13(2): 125-129.
[10]Kolomainen DF, Larkin JM, Badran M, et al.Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence[J]. J Clin Oncol, 2002, 20(4):982-986.
[11]徐漫漫， 李俊东，黄永文，等.卵巢上皮性癌脑转移 13 例临床分析[J]. 中国实用妇科与产科杂志,2013,29(2):135-139.
[12]Nguyen TD, DeAngelis LM. Brain metastases[J]. Neurol Clin, 2007,25(4):1173-1192.
[13]Choo BA, Walji N, Spooner D, et al. Prolonged relapse-free survival in two patients with an isolated brain metastasis from epithelial ovarian carcinoma[J].J Clin Oncol, 2010，28(17): 271-272.
[14]Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone[J]. Int J Radiat Oncol Biol Phys，2007，68(5):1388-1395.
[15]Hazard LJ, Jensen RL, Shrieve DC. Role of stereotactic radiosurgery in the treatment of brain metastases[J]. Am J Clin Oncol,2005，28: 403-410.
[16]李东石，程惠华，陈 苏，等.脑转移瘤X线立体定向放射治疗临床分析[J].东南国防医药，2002, 4(2):10-11.
[17]Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline[J]. J Neurooncol, 2010，96(1):45-68.
[18]Nishizaki T, Saito K, Jimi Y, et al. The role of cyberknife radiosurgery radiotherapy for brain metastases of multiple or large-size tumors[J].Minim Invas Neurosurg, 2006，49（4）: 203-209.
[19]Pectasides D, Aravantinos G, Fountzilas G, et al. Brain metastases from epithelial ovarian Cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature[J]. Anticancer Res, 2005, 25(5): 3553-3558.
[20]Chiang YC, Qiu JT, Chang CL,et al. Brain metastases from epithelial ovarian carcinoma evaluation of prognosis and managements-a Taiwanese Gynecologic Oncology Group (TGOG) study[J]. Gynecol Oncol, 2012, 125(1): 37-41.
[21]Sekine M, Yoshihara K, Komata D, et al.Increased incidence of brain metastases in BRCA1-related ovarian cancers[J]. J Obstet Gynaecol Res, 2013, 39(1): 292-296.
[22]Tuncer ZS, Boyraz G, Yazicioglu A, et al. Brain metastasis as an initial manifestation of ovarian carcinoma: a case report [J].Case Rep Med, 2012, DOI: 10.1155/2012/735026.
[23]Faluyi OO, Gourley C, Smyth JF, et al. High incidence of isolated brain metastases in ovarian Cancer patients with previous early breast cancer [J]. Int J Gynecol Cancer, 2010, 20(9): 1511-1517.
[24]Brastianos PK, Carter SL, Santagata S, et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets[J].Cancer Discov，2015，5(11):1164-1177.

相似文献/References:

[1]李彩云,龚谋春,潘建虎,等.卵巢癌二次探查手术前PET-CT检查的作用及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2013,15(02):141.
　.Department of Obstetrics and Gynecology.PET-CT Center7 Hospital of PLA,Hangzhou,Zhejiang 00,et al.LI Cai-yun1,GONG Mou-chun1,PAN Jian-hu2[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(02):141.
[2]孙 健,卢 健,邹冬芳,等.结肠腺瘤性息肉病基因异常甲基化在 上皮性卵巢癌中的检测及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2008,10(06):414.
　SUN Jian,LU Jian,ZOU Dong-fang,et al.Significance of hypermethylation of APC in epithelial ovarian carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(02):414.
[3]朱饮源,姚 军,李 曼.糖原合成酶激酶3β对卵巢癌紫杉醇耐药性的影响及机制研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(01):29.[doi:10.3969/j.issn.1672-271X.2015.01.009]
　ZHU Yin-yuan,YAO Jun,LI Man..The effects of GSK-3β on paclitaxel chemoresistance of ovarian cancer cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(02):29.[doi:10.3969/j.issn.1672-271X.2015.01.009]
[4]陈 慧,张 兰,郭以河,等.Eag1钾离子通道在卵巢癌组织中的表达及意义[J].医学研究与战创伤救治(原医学研究生学报),2016,18(01):17.[doi:10.3969/j.issn.1672-271X.2016.01.005]
　CHEN Hui,ZHANG Lan,GUO Yi-he,et al.Expression and significance ofether à go-go 1 channels in human ovarian cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(02):17.[doi:10.3969/j.issn.1672-271X.2016.01.005]
[5]洪丽君,曾清芳,卢昆林,等.高尔基体磷蛋白3在卵巢癌中的表达及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2017,19(04):357.[doi:10.3969/j.issn.1672-271X.2017.04.006]
　HONG Li-jun,ZENG Qing-fang,LU Kun-lin,et al.Expression and clinical significance of Golgi phosphoprotein 3 in ovarian cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(02):357.[doi:10.3969/j.issn.1672-271X.2017.04.006]
[6]杨帆,谢树红综述,黄惠娟审校.卵巢癌在代谢组学中的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2018,20(02):160.[doi:10.3969/j.issn.1672-271X.2018.02.012]
[7]谢树红,黄惠娟,许玉黎,等.橄榄苦苷对体外卵巢癌SKOV3细胞增殖的影响[J].医学研究与战创伤救治(原医学研究生学报),2018,20(04):361.[doi:10.3969/j.issn.1672-271X.2018.04.008]
　XIE Shu-hong,HUANG Hui-juan,XU Yu-li,et al.Effects ofoleuropein on proliferation of ovarian cancer SKOV3 cells in vitro[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(02):361.[doi:10.3969/j.issn.1672-271X.2018.04.008]
[8]许玉黎,黄惠娟,谢树红,等.橄榄苦苷对卵巢癌裸鼠皮下移植瘤抑瘤作用的研究[J].医学研究与战创伤救治(原医学研究生学报),2018,20(06):561.[doi:10.3969/j.issn.1672-271X.2018.06.001]
　XU Yu-li,HUANG Hui-juan,XIE Shu-hong,et al.Study on antitumor effects of oleuropein on ovarian cancer subcutaneous transplanted tumor in nude mice[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(02):561.[doi:10.3969/j.issn.1672-271X.2018.06.001]
[9]陈娟,刘传丽,陈艳思,等.IL-17A在卵巢癌中的表达水平及潜在机制的生物信息学分析[J].医学研究与战创伤救治(原医学研究生学报),2020,22(01):25.[doi:10.3969/j.issn.1672-271X.2020.01.006]
　CHENJuan,LIUChuan-li,CHENYan-si,et al.The expression level of IL-17A in ovarian cancer and the bioinformatics analysis of potential mechanism[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(02):25.[doi:10.3969/j.issn.1672-271X.2020.01.006]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2016-03-20